34 related articles for article (PubMed ID: 1381218)
1. A phase I trial of recombinant gamma interferon in patients with cancer.
Foon KA; Sherwin SA; Abrams PG; Stevenson HC; Holmes P; Maluish AE; Oldham RK; Herberman RB
Cancer Immunol Immunother; 1985; 20(3):193-7. PubMed ID: 3933818
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.
Liberati AM; Horisberger M; Schippa M; Di Clemente F; Fizzotti M; Filippo S; Proietti MG; Arzano S; Berruto P; Palmisano L
Cancer Immunol Immunother; 1991; 34(2):115-22. PubMed ID: 1760815
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil functions in patients with neutropenia due to glycogen storage disease type 1b treated with empagliflozin.
Kaczor M; Malicki S; Folkert J; Dobosz E; Bryzek D; Chruscicka-Smaga B; Greczan M; Wesół-Kucharska D; Piątosa B; Samborowska E; Madzio J; Książyk J; Ehmke Vel Emczyńska E; Hajdacka M; Potempa J; Młynarski W; Rokicki D; Veillard F
Blood Adv; 2024 Jun; 8(11):2790-2802. PubMed ID: 38531056
[TBL] [Abstract][Full Text] [Related]
4. Engineering a New IFN-ApoA-I Fusion Protein with Low Toxicity and Prolonged Action.
Miroshnichenko S; Pykhtina M; Kotliarova A; Chepurnov A; Beklemishev A
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138504
[TBL] [Abstract][Full Text] [Related]
5. The role of interferon in the treatment of hairy cell leukemia.
Ratain MJ; Vardiman JW; Golomb HM
Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia.
Lorber C; Willfort A; Ohler L; Jäger U; Schwarzinger I; Lechner K; Geissler K
Ann Hematol; 1993 Jul; 67(1):13-6. PubMed ID: 7687471
[TBL] [Abstract][Full Text] [Related]
7. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
[TBL] [Abstract][Full Text] [Related]
9. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
10. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hairy-cell leukemia.
Lill MC; Golde DW
Blood Rev; 1990 Dec; 4(4):238-44. PubMed ID: 1706207
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]